Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work.
Jonathan R Schettino, Katherine Cheung, Sandeep M. Nayak, Brandon M Weiss, David B. Yaden
General Hospital Psychiatry 2026 DOI: 10.1016/j.genhosppsych.2025.12.021 (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Psychedelic Psychological support Psychotherapy |
| Key points | Argues that current debate over whether interpersonal interaction in psychedelic studies is psychological support or psychotherapy is unproductive due to lack of shared definitions, and that higher-quality data are needed to distinguish them. |
Abstract
Classic psychedelic studies involve interpersonal interactions with participants before, during, and after the acute effects of psychedelics. In the field of psychedelic research, there is currently a debate about whether this interpersonal interaction is most accurately considered "psychological support," "psychotherapy," or something else. Proponents of the psychological support label describe the interpersonal interaction in most classic psychedelic studies as aimed at safety, while proponents of the psychotherapy label argue that the interpersonal interaction involves intervening on psychotherapeutic processes that not only support safety, but also contribute to treatment efficacy. However, we believe that the debate has so far been largely unproductive due to a lack of shared definitions or criteria for the relevant interpersonal interactions. Here, we propose definitions and criteria for two viable forms of interpersonal interaction in psychedelic administration: one directed solely towards safety (psychological support) and one directed towards both safety and efficacy (psychotherapy). We then trial our proposed criteria on a sample of 11 published classic psychedelic clinical trials. Our procedure categorized 10 out of 11 studies as being more or less consistent with psychological support or psychotherapy, but achieved clear distinctions in only 4 out of 11 studies. Given these findings, we argue that higher quality data on the interpersonal interaction is needed to clearly distinguish between psychological support and psychotherapy. We conclude by suggesting ways that our criteria can be used in the future to empirically test the relative safety and efficacy of psychological support vs. psychotherapy in psychedelic medicine.
Citations in the library
Cited by 8
- Setting, context and the regulatory atmospheres of psychedelic medicine. International Journal of Drug Policy July 1, 2026
- Esketamine and Acceptance and Commitment Therapy (ACT) for Treatment-Resistant Depression: An Intervention-Development Framework and Treatment Manual Psychedelics October 1, 2026
- Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study. BMJ Open July 13, 2026
- Psychedelics in Mental Health: Opportunities and Challenges. Brain and Behavior July 1, 2026
- T-shaped expertise: rethinking interdisciplinarity in psychedelic research Psychedelics June 28, 2026
and 3 more in the library
Cites 16
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
- Single-Dose Psilocybin Treatment for Major Depressive Disorder JAMA August 31, 2023
- A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy Journal of Psychoactive Drugs June 12, 2020
and 11 more in the library